Want to see SE:PILA full AI Analyst Report?
PILA PHARMA AB (PILA) Ratios
PILA PHARMA AB Ratios
SE:PILA's free cash flow for Q2 2026 was $-8.99M. For the 2026 fiscal year, SE:PILA's free cash flow was increased by $0.00 and operating cash flow was $-8.99M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 11.26 | 5.21 | 3.48 | 5.59 | 18.81 |
| Quick Ratio | 11.26 | 5.21 | 3.48 | 5.85 | 19.00 |
| Cash Ratio | 11.09 | 5.09 | 3.32 | 5.34 | 18.62 |
| Solvency Ratio | -11.01 | -10.55 | -4.93 | -19.72 | -11.35 |
| Operating Cash Flow Ratio | -6.41 | -8.13 | -2.71 | -6.70 | -6.18 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | -6.28 | 0.00 | 0.00 |
| Net Current Asset Value | $ 14.72M | $ 4.05M | $ 4.44M | $ 6.23M | $ 26.98M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.00 | 0.09 | 0.00 | 0.00 |
| Debt-to-Equity Ratio | 0.00 | 0.00 | 0.12 | 0.00 | 0.00 |
| Debt-to-Capital Ratio | 0.00 | 0.00 | 0.10 | 0.00 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.10 | 1.18 | 1.27 | 1.14 | 1.05 |
| Debt Service Coverage Ratio | -72.70 | -190.78 | -10.84 | -40669.37 | -561.72 |
| Interest Coverage Ratio | -36.05 | -153.00 | -159.48 | -13510.78 | -303.20 |
| Debt to Market Cap | 0.00 | 0.00 | 0.02 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.01 | 0.00 | 0.04 | 0.00 | 0.00 |
| Net Debt to EBITDA | 1.00 | 0.48 | 0.59 | 0.27 | 1.64 |
| Profitability Margins | |||||
| Gross Profit Margin | -604.88% | -1048.28% | 100.00% | 100.00% | 94.68% |
| EBIT Margin | -1508.34% | -1443.61% | -675.99% | -1423.70% | -2388.21% |
| EBITDA Margin | -1412.73% | -1304.67% | -602.35% | -1422.87% | -2385.41% |
| Operating Profit Margin | -700.44% | -1046.32% | -436.99% | -472.69% | -1287.57% |
| Pretax Profit Margin | -1496.27% | -1450.45% | -678.73% | -1423.74% | -2392.46% |
| Net Profit Margin | -1496.27% | -1450.45% | -678.73% | -1423.74% | -2392.46% |
| Continuous Operations Profit Margin | -1496.27% | -1450.45% | -678.73% | -1423.74% | -2392.46% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 213.62% | 138.62% | 155.32% | 301.20% | 185.81% |
| Return on Assets (ROA) | -103.98% | -180.61% | -117.44% | -245.95% | -54.09% |
| Return on Equity (ROE) | -114.06% | -213.67% | -149.07% | -280.98% | -56.80% |
| Return on Capital Employed (ROCE) | -53.40% | -154.10% | -95.97% | -93.29% | -30.57% |
| Return on Invested Capital (ROIC) | -53.40% | -154.13% | -85.99% | -93.29% | -30.57% |
| Return on Tangible Assets | -103.98% | -218.40% | -157.60% | -349.81% | -60.21% |
| Earnings Yield | -23.65% | -11.77% | -29.41% | -50.14% | -18.89% |
| Efficiency Ratios | |||||
| Receivables Turnover | 4.42 | 6.39 | 5.20 | 5.42 | 2.50 |
| Payables Turnover | 34.09 | 20.04 | 19.73 | 30.79 | 0.11 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | -31.03 | -0.13 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 46.02 |
| Asset Turnover | 0.07 | 0.12 | 0.17 | 0.17 | 0.02 |
| Working Capital Turnover Ratio | 0.12 | 0.18 | 0.27 | 0.11 | 0.05 |
| Cash Conversion Cycle | 71.88 | 38.92 | 51.73 | 43.74 | -5963.16 |
| Days of Sales Outstanding | 82.59 | 57.13 | 70.23 | 67.36 | 146.27 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | -11.76 | -2747.49 |
| Days of Payables Outstanding | 10.71 | 18.21 | 18.50 | 11.85 | 3361.94 |
| Operating Cycle | 82.59 | 57.13 | 70.23 | 55.60 | -2601.22 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.27 | -0.31 | -0.23 | -0.53 | -0.70 |
| Free Cash Flow Per Share | -0.27 | -0.31 | -0.23 | -0.53 | -0.70 |
| Dividend Paid and CapEx Coverage Ratio | 0.00 | -1955750.00 | 0.00 | 0.00 | 0.00 |
| Capital Expenditure Coverage Ratio | 0.00 | -1955750.00 | 0.00 | 0.00 | 0.00 |
| Operating Cash Flow Coverage Ratio | 0.00 | 0.00 | -6.28 | 0.00 | 0.00 |
| Operating Cash Flow to Sales Ratio | -8.15 | -10.09 | -3.32 | -4.83 | -13.02 |
| Free Cash Flow Yield | -12.89% | -8.19% | -14.38% | -17.02% | -10.28% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -4.20 | -8.52 | -3.40 | -1.99 | -5.29 |
| Price-to-Sales (P/S) Ratio | 63.25 | 123.19 | 23.08 | 28.39 | 126.67 |
| Price-to-Book (P/B) Ratio | 4.82 | 18.15 | 5.07 | 5.60 | 3.01 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -7.76 | -12.20 | -6.96 | -5.87 | -9.73 |
| Price-to-Operating Cash Flow Ratio | -7.76 | -12.20 | -6.96 | -5.87 | -9.73 |
| Price-to-Earnings Growth (PEG) Ratio | -0.37 | 1.34 | 0.05 | -0.11 | -0.05 |
| Enterprise Value Multiple | -3.48 | -8.96 | -3.24 | -1.72 | -3.67 |
| Enterprise Value | 55.39M | 90.58M | 28.58M | 46.16M | 62.90M |
| EV to EBITDA | -3.48 | -8.96 | -3.24 | -1.72 | -3.67 |
| EV to Sales | 49.15 | 116.88 | 19.53 | 24.54 | 87.45 |
| EV to Free Cash Flow | -6.03 | -11.58 | -5.89 | -5.08 | -6.72 |
| EV to Operating Cash Flow | -6.03 | -11.58 | -5.89 | -5.08 | -6.72 |
| Tangible Book Value Per Share | 0.43 | 0.16 | 0.21 | 0.36 | 2.02 |
| Shareholders’ Equity Per Share | 0.43 | 0.21 | 0.32 | 0.55 | 2.26 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.03 | 0.03 | 0.07 | 0.11 | 0.05 |
| Net Income Per Share | -0.49 | -0.44 | -0.47 | -1.55 | -1.28 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 0.99 | 1.00 | 1.00 | 1.00 | 1.00 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 11.46 | 0.00 | 0.00 | 7.05 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.54 | 0.70 | 0.49 | 0.34 | 0.54 |
Currency in SEK